Sun Pharmaceuticals earned the highest revenue from its cardic drug formulation, Rosuvas, with a value of over 3.8 billion Indian rupees in February 2022. This was closely followed by their pain and analgesics formulation, Volini that same year.
Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India
Market overview
6
- Premium Statistic Revenue of the OTC pharmaceuticals in selected countries worldwide
- Basic Statistic Top pharma companies worldwide by number of originated drugs 2023
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Distribution of therapies in Indian pharmaceuticals 2022
- Premium Statistic Share of pharmacy in organized retail India FY 2020-2022
- Premium Statistic Leading pharmaceutical and drug companies India 2023, by market capitalization
GSK India - key figures
6
- Premium Statistic GSK's revenue by region 2013-2023
- Premium Statistic GSK's number of employees by region 2011-2023
- Premium Statistic GSK Pharmaceuticals' number of employees in India FY 2016-2023
- Premium Statistic GSK Pharmaceuticals' operation revenue in India FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
Product portfolio
3
Main competitiors
4
Further related statistics
18
- Alembic Pharma India revenue 2022, by leading therapy drug
- MAT of therapies in Indian pharma 2022
- Distribution of therapies in Indian pharmaceuticals 2022
- Growth rate of top therapies in Indian pharmaceuticals 2022
- Sun Pharma's market share of therapy drugs India 2022
- Revenue Cadila Healthcare India 2022, by leading therapy drug
- Market share of therapy drugs by Cadila Healthcare India 2022
- Members of EFPIA's pharmaceutical market value 2000-2022
- Pharma revenue share worldwide 2017, by country
- Sales value of drugs to treat the respiratory system in Italy 2013-20220
- Import value of pharmaceutical drugs to GCC 2011-2015
- Value of pharmaceutical drugs imports in Turkey 2013-2015
- Import value of vaccines from Saudi Arabia to GCC 2011-2015
- EBT of pharmaceutical companies in Italy 2016-2018
- Number of financial pharmaceutical deals in China 2016-2019, by type
- Sales revenue Kwang Dong Pharmaceutical 2011-2022
- Growth rate of therapy drugs by Cadila Healthcare India 2022
- Value share of pharma market worldwide 2015 vs. 2021, by subsector
Further Content: You might find this interesting as well
Statistics
- Alembic Pharma India revenue 2022, by leading therapy drug
- MAT of therapies in Indian pharma 2022
- Distribution of therapies in Indian pharmaceuticals 2022
- Growth rate of top therapies in Indian pharmaceuticals 2022
- Sun Pharma's market share of therapy drugs India 2022
- Revenue Cadila Healthcare India 2022, by leading therapy drug
- Market share of therapy drugs by Cadila Healthcare India 2022
- Members of EFPIA's pharmaceutical market value 2000-2022
- Pharma revenue share worldwide 2017, by country
- Sales value of drugs to treat the respiratory system in Italy 2013-20220
- Import value of pharmaceutical drugs to GCC 2011-2015
- Value of pharmaceutical drugs imports in Turkey 2013-2015
- Import value of vaccines from Saudi Arabia to GCC 2011-2015
- EBT of pharmaceutical companies in Italy 2016-2018
- Number of financial pharmaceutical deals in China 2016-2019, by type
- Sales revenue Kwang Dong Pharmaceutical 2011-2022
- Growth rate of therapy drugs by Cadila Healthcare India 2022
- Value share of pharma market worldwide 2015 vs. 2021, by subsector
Motilal Oswal Group. (March 8, 2022). Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph]. In Statista. Retrieved April 28, 2024, from https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees)." Chart. March 8, 2022. Statista. Accessed April 28, 2024. https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. (2022). Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees). Statista. Statista Inc.. Accessed: April 28, 2024. https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by Leading Therapy Drug (in Billion Indian Rupees)." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/
Motilal Oswal Group, Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) Statista, https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/ (last visited April 28, 2024)
Revenue of Sun Pharmaceutical Industries Limited across India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/1096917/india-sun-pharma-revenue-by-therapy-drugs/